Phase II study of antineoplaston A10 and AS2-1 capsules in patients with incurable, stage C or D adenocarcinoma of the prostate
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 30 Jan 2018 Status changed from active, no longer recruiting to discontinued due to slow accrual.
- 30 Sep 2005 New trial record.